Figure 2
Results of the questionnaires for cervical cancer, TC, paclitaxel + carboplatin; TP, paclitaxel + cisplatin; Bev, bevacizumab.

Results of the questionnaires for cervical cancer, TC, paclitaxel + carboplatin; TP, paclitaxel + cisplatin; Bev, bevacizumab.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close